Literature DB >> 21875754

Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease.

Burçak Vural1, Elif Uğurel, Erdem Tüzün, Murat Kürtüncü, Luigi Zuliani, Filiz Cavuş, Sema Içöz, Ece Erdağ, Ahmet Gül, Ali O Güre, Angela Vincent, Uğur Ozbek, Mefkure Eraksoy, Gülşen Akman-Demir.   

Abstract

No disease-specific neuronal antibodies have so far been defined in neuro-Behçet's disease (NBD). Immunohistochemistry and immunocytochemistry studies showed antibodies to hippocampal and cerebellar molecular layers and the surface antigens of cultured hippocampal neurons in sera and/or cerebrospinal fluids (CSF) of 13 of 20 NBD and 6 of 20 BD patients but not in multiple sclerosis or headache controls. Screening with a protein macroarray led to identification of stress-induced-phosphoprotein-1 (STIP-1) as an antigenic target. High-titer STIP-1-antibodies were detected in 6 NBD patients' sera but not in controls. These results suggest that neuronal antibodies could be useful as diagnostic biomarkers in NBD. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875754     DOI: 10.1016/j.jneuroim.2011.08.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.

Authors:  Ece Erdağ; Erdem Tüzün; Elif Uğurel; Filiz Cavuş; Elçin Sehitoğlu; Murat Giriş; Burçak Vural; Mefküre Eraksoy; Gülşen Akman-Demir
Journal:  Inflamm Res       Date:  2012-05-22       Impact factor: 4.575

2.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Authors:  I S Piras; L Haapanen; V Napolioni; R Sacco; J Van de Water; A M Persico
Journal:  Brain Behav Immun       Date:  2014-01-03       Impact factor: 7.217

3.  Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG.

Authors:  Ece Erdağ; Ceren Şahin; Cem İsmail Küçükali; Sinem Bireller; Melike Küçükerden; Murat Kürtüncü; Recai Türkoğlu; Bedia Cakmakoglu; Erdem Tüzün; Feyza Arıcıoğlu
Journal:  Neurol Sci       Date:  2017-02-21       Impact factor: 3.307

4.  The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.

Authors:  Ayşe İlksen Colpak; Umut Kalyoncu; Yasemin Gürsoy Özdemir
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

5.  Impact of Neuro-Behçet Disease Immunoglobulin G on Neuronal Apoptosis.

Authors:  Murat Giriş; Sinem Bireller; Cem İsmail Küçükali; Haşmet Hanağasi; Sevgin Değirmencioğlu; Erdem Tüzün
Journal:  Noro Psikiyatr Ars       Date:  2016-12-08       Impact factor: 1.339

6.  Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study.

Authors:  Elçin Sehitoğlu; Filiz Cavuş; Canan Ulusoy; Melike Küçükerden; Arda Orçen; Deniz Akbaş-Demir; Arzu Coban; Burçak Vural; Erdem Tüzün; Recai Türkoğlu
Journal:  Inflamm Res       Date:  2014-07-08       Impact factor: 4.575

Review 7.  Behçet's Disease and Nervous System Involvement.

Authors:  Murat Kürtüncü; Erdem Tüzün; Gulsen Akman-Demir
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.598

8.  Autism-specific maternal autoantibodies recognize critical proteins in developing brain.

Authors:  D Braunschweig; P Krakowiak; P Duncanson; R Boyce; R L Hansen; P Ashwood; I Hertz-Picciotto; I N Pessah; J Van de Water
Journal:  Transl Psychiatry       Date:  2013-07-09       Impact factor: 6.222

Review 9.  Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease.

Authors:  H Direskeneli
Journal:  Genet Res Int       Date:  2013-12-31

10.  A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells.

Authors:  Ketan S Patil; Indranil Basak; Ramavati Pal; Hsin-Pin Ho; Guido Alves; Emmanuel J Chang; Jan Petter Larsen; Simon Geir Møller
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.